PPD expands Asian lab services with Singapore facility
This article was originally published in Scrip
Executive Summary
PPD is setting up a new central laboratory services unit in Singapore to meet what it says is growing demand from regional clients. The new facility is scheduled to begin operations in the middle of next year and will provide a variety of customised services in line with those at other similar centres in the US, Europe and China. It will reduce sample processing times and costs for customers in Asia and be linked to PPD's global online system, the US-based contract research organisation notes. The company already offers various clinical development and regulatory services through its Singapore office.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.